Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.

De Rechter S, Bammens B, Schaefer F, Liebau MC, Mekahli D.

Clin Kidney J. 2018 Dec;11(Suppl 1):i14-i26. doi: 10.1093/ckj/sfy088. Epub 2018 Dec 17. Review.

2.

Simultaneous determination of allantoin and adenosine in human urine using liquid chromatography - UV detection.

Andries A, De Rechter S, Janssens P, Mekahli D, Van Schepdael A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Oct 1;1096:201-207. doi: 10.1016/j.jchromb.2018.08.026. Epub 2018 Aug 27.

PMID:
30176509
3.

Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study.

Janssens P, Van Hoeve K, De Waele L, De Rechter S, Claes KJ, Van de Perre E, Wissing KM, Bammens B, Jansen A, Mekahli D.

Pediatr Nephrol. 2018 Nov;33(11):2085-2093. doi: 10.1007/s00467-018-4003-6. Epub 2018 Jul 9.

PMID:
29987458
4.

Prevalence of Hypertension in Children with Early-Stage ADPKD.

Massella L, Mekahli D, Paripović D, Prikhodina L, Godefroid N, Niemirska A, Ağbaş A, Kalicka K, Jankauskiene A, Mizerska-Wasiak M, Afonso AC, Salomon R, Deschênes G, Ariceta G, Özçakar ZB, Teixeira A, Duzova A, Harambat J, Seeman T, Hrčková G, Lungu AC, Papizh S, Peco-Antic A, De Rechter S, Giordano U, Kirchner M, Lutz T, Schaefer F, Devuyst O, Wühl E, Emma F.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):874-883. doi: 10.2215/CJN.11401017. Epub 2018 Apr 19.

5.

Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?

De Rechter S, Breysem L, Mekahli D.

Front Pediatr. 2017 Dec 20;5:272. doi: 10.3389/fped.2017.00272. eCollection 2017. Review.

6.

3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease.

Breysem L, De Rechter S, De Keyzer F, Smet MH, Bammens B, Van Dyck M, Hofmans M, Oyen R, Levtchenko E, Mekahli D.

Pediatr Nephrol. 2018 May;33(5):827-835. doi: 10.1007/s00467-017-3862-6. Epub 2018 Jan 6.

PMID:
29306987
7.

Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney Disease.

De Rechter S, Bacchetta J, Godefroid N, Dubourg L, Cochat P, Maquet J, Raes A, De Schepper J, Vermeersch P, Van Dyck M, Levtchenko E, D'Haese P, Evenepoel P, Mekahli D.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4210-4217. doi: 10.1210/jc.2017-01157.

PMID:
29092060
8.

Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.

De Rechter S, Kringen J, Janssens P, Liebau MC, Devriendt K, Levtchenko E, Bergmann C, Jouret F, Bammens B, Borry P, Schaefer F, Mekahli D.

PLoS One. 2017 Sep 29;12(9):e0185779. doi: 10.1371/journal.pone.0185779. eCollection 2017.

9.

Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?

Janssens P, Weydert C, De Rechter S, Wissing KM, Liebau MC, Mekahli D.

Pediatr Nephrol. 2018 Mar;33(3):395-408. doi: 10.1007/s00467-017-3672-x. Epub 2017 Apr 28. Review.

PMID:
28455745
10.

The Case | Hypercalcemia in a child with chronic kidney disease.

De Rechter S, Levtchenko E, Evenepoel P, Mekahli D.

Kidney Int. 2016 Jul;90(1):233-4. doi: 10.1016/j.kint.2015.12.060. No abstract available.

PMID:
27312459
11.

Home Telehealth Video Conferencing: Perceptions and Performance.

Taylor A, Morris G, Pech J, Rechter S, Carati C, Kidd MR.

JMIR Mhealth Uhealth. 2015 Sep 17;3(3):e90. doi: 10.2196/mhealth.4666.

12.

Technology support to a telehealth in the home service: Qualitative observations.

Taylor A, Wade V, Morris G, Pech J, Rechter S, Kidd M, Carati C.

J Telemed Telecare. 2016 Jul;22(5):296-303. doi: 10.1177/1357633X15601523. Epub 2015 Sep 11.

PMID:
26362562
13.

Autophagy in renal diseases.

De Rechter S, Decuypere JP, Ivanova E, van den Heuvel LP, De Smedt H, Levtchenko E, Mekahli D.

Pediatr Nephrol. 2016 May;31(5):737-52. doi: 10.1007/s00467-015-3134-2. Epub 2015 Jul 4. Review.

PMID:
26141928
14.

Charcot-Marie-Tooth: are you testing for proteinuria?

De Rechter S, De Waele L, Levtchenko E, Mekahli D.

Eur J Paediatr Neurol. 2015 Jan;19(1):1-5. doi: 10.1016/j.ejpn.2014.08.004. Epub 2014 Aug 28. Review.

PMID:
25439738
15.

Arthroscopic treatment for snapping scapula: a prospective case series.

Blønd L, Rechter S.

Eur J Orthop Surg Traumatol. 2014 Feb;24(2):159-64. doi: 10.1007/s00590-012-1154-1. Epub 2013 Jan 5.

PMID:
23412302
16.

Cytomegaloviral protein kinase pUL97 interacts with the nuclear mRNA export factor pUL69 to modulate its intranuclear localization and activity.

Thomas M, Rechter S, Milbradt J, Auerochs S, Müller R, Stamminger T, Marschall M.

J Gen Virol. 2009 Mar;90(Pt 3):567-78. doi: 10.1099/vir.0.005827-0.

PMID:
19218201
17.

Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.

Rechter S, Scott GM, Eickhoff J, Zielke K, Auerochs S, Müller R, Stamminger T, Rawlinson WD, Marschall M.

J Biol Chem. 2009 Mar 27;284(13):8605-13. doi: 10.1074/jbc.M805693200. Epub 2009 Jan 29.

18.

Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo.

Schleiss M, Eickhoff J, Auerochs S, Leis M, Abele S, Rechter S, Choi Y, Anderson J, Scott G, Rawlinson W, Michel D, Ensminger S, Klebl B, Stamminger T, Marschall M.

Antiviral Res. 2008 Jul;79(1):49-61. doi: 10.1016/j.antiviral.2008.01.154. Epub 2008 Feb 22.

PMID:
18329738
20.

Antiviral activity of Arthrospira-derived spirulan-like substances.

Rechter S, König T, Auerochs S, Thulke S, Walter H, Dörnenburg H, Walter C, Marschall M.

Antiviral Res. 2006 Dec;72(3):197-206. Epub 2006 Jun 30.

PMID:
16884788
21.
22.

PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.

Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A.

J Virol. 2006 Aug;80(16):7995-8005.

23.

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.

Kaptein SJ, Efferth T, Leis M, Rechter S, Auerochs S, Kalmer M, Bruggeman CA, Vink C, Stamminger T, Marschall M.

Antiviral Res. 2006 Feb;69(2):60-9. Epub 2005 Nov 21.

PMID:
16325931
24.

[Influence of myocardial mass of the univentricular heart on exercise capacity in patients with functional single ventricle and Fontan surgery].

Niepage S, Schulze-Neick I, Rechter S, Abdul-Khaliq H, Gutberlet M, Alexi-Meskishvili V, Hetzer R, Lange PE.

Z Kardiol. 2004 Mar;93(3):222-8. German.

PMID:
15024590
25.

Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus.

Scholz B, Rechter S, Drach JC, Townsend LB, Bogner E.

Nucleic Acids Res. 2003 Mar 1;31(5):1426-33.

26.

[The value of magnetic resonance tomography (MRT) for evaluating ventricular and anastomotic functions in patients with an extra- or intracardiac total cavopulmonary connection (TCPC)-modified Fontan operation].

Gutberlet M, Hosten N, Abdul-Khaliq H, Rechter S, Vojtovic P, Oellinger H, Ehrenstein T, Vogel M, Alexi-Meshkishvili V, Hetzer R, Felix R.

Rofo. 1999 Dec;171(6):431-41. German.

PMID:
10668507

Supplemental Content

Loading ...
Support Center